Novan presents preliminary phase II results for SB-206 as treatment of molluscum contagiosum Nov. 15, 2018 No Comments
Promising interim results presented from phase IIa study of CTP-543 in patients with alopecia areata Nov. 13, 2018 No Comments
Novel RORgammat inhibitors developed by Shionogi for treating Th17-mediated autoimmune diseases Nov. 12, 2018 No Comments
Discovery and optimization of Aurora B-selective SYK inhibitors as topical agents for skin diseases Nov. 8, 2018 No Comments
Positive topline results presented from phase III program evaluating FMX-103 Nov. 8, 2018 No Comments
RSS